Gamma entrainment therapy to restore motor cortical inhibitory-excitatory balance in ALS

Gamma entrainment therapy (GET) in Alzheimer's restores hippocampal-cortical synchrony by enhancing PV+ and SST interneuron function to reduce excitatory-inhibitory (E/I) imbalance. In ALS, motor cortex exhibits cortical hyperexcitability partially attributable to GABAergic dysfunction and reduced PV+ interneuron activity. We hypothesize that 40 Hz auditory-visual gamma entrainment can similarly enhance PV+ interneuron-mediated inhibition in the motor cortex, reducing excitotoxic stress on upper motor neurons and slowing disease progression.

Analogy rationale: Both AD and familial ALS show E/I imbalance; AD via amyloid-driven PV+ dysfunction and ALS via SOD1/TDP-43 pathology affecting inhibitory networks. Gamma entrainment potently drives PV+ firing and perisomatic inhibition in both cortical regions, suggesting the circuit mechanism is conserved between hippocampus and motor cortex.

Gamma entrainment therapy (GET) in Alzheimer's restores hippocampal-cortical synchrony by enhancing PV+ and SST interneuron function to reduce excitatory-inhibitory (E/I) imbalance. In ALS, motor cortex exhibits cortical hyperexcitability partially attributable to GABAergic dysfunction and reduced PV+ interneuron activity. We hypothesize that 40 Hz auditory-visual gamma entrainment can similarly enhance PV+ interneuron-mediated inhibition in the motor cortex, reducing excitotoxic stress on upper motor neurons and slowing disease progression.

Analogy rationale: Both AD and familial ALS show E/I imbalance; AD via amyloid-driven PV+ dysfunction and ALS via SOD1/TDP-43 pathology affecting inhibitory networks. Gamma entrainment potently drives PV+ firing and perisomatic inhibition in both cortical regions, suggesting the circuit mechanism is conserved between hippocampus and motor cortex.

Disanalogies: AD pathology originates in cortex with interneuron involvement as primary mechanism, whereas ALS pathology begins in motor neurons with interneuron changes likely secondary. Additionally, the therapeutic target in ALS is protecting vulnerable UMNs rather than restoring cognition-dependent synchrony.

Falsifiable prediction: 40 Hz gamma entrainment (10 min/day, 4 weeks) in SOD1*G93A mice will increase motor cortex PV+ cell count and GAD1 expression, reduce cortical hyperexcitability on TMS-like electrophysiology, and extend survival by ≥10% compared to sham-treated controls.
This hypothesis was generated from `h-bdbd2120` in `Alzheimer's disease` — judge it on its own merits but acknowledge the source.